B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
-7.84%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.19B
AUM Growth
+$3.19B
(+2.7%)
Cap. Flow
+$348M
Cap. Flow
% of AUM
10.93%
Top 10 Holdings %
Top 10 Hldgs %
36.68%
Holding
89
New
17
Increased
26
Reduced
11
Closed
10
Top Buys
| 1 |
CG Oncology
CGON
|
$68.8M |
| 2 |
Xenon Pharmaceuticals
XENE
|
$48.8M |
| 3 |
Exact Sciences
EXAS
|
$48.2M |
| 4 |
Spyre Therapeutics
SYRE
|
$47M |
| 5 |
Inspire Medical Systems
INSP
|
$37.2M |
Top Sells
| 1 |
Transmedics
TMDX
|
$63.9M |
| 2 |
Vaxcyte
PCVX
|
$30.5M |
| 3 |
argenx
ARGX
|
$22.7M |
| 4 |
Tourmaline Bio
TRML
|
$20.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$19.1M |
Sector Composition
| 1 | Healthcare | 60.98% |
| 2 | Consumer Staples | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $104M | 3.28% | 759,009 +28,800 | +4% | +$3.96M |
|
|
2
CG Oncology
CGON
$2.04B
| $104M | 3.28% | 3,309,507 +2,179,272 | +193% | +$68.8M |
|
|
3
Xenon Pharmaceuticals
XENE
$2.98B
| $99.8M | 3.13% | 2,560,573 +1,252,562 | +96% | +$48.8M |
|
4
Apogee Therapeutics
APGE
$2.17B
| $94.1M | 2.95% | 2,392,042 +549,527 | +30% | +$21.6M |
|
5
Guardant Health
GH
$8.41B
| $81.1M | 2.54% | 2,807,968 +331,164 | +13% | +$9.56M |
|
6
Legend Biotech
LEGN
$6.41B
| $74M | 2.32% | 1,669,720 +425,925 | +34% | +$18.9M |
|
|
7
argenx
ARGX
$43.6B
| $71.8M | 2.25% | 166,924 -52,900 | -24% | -$22.7M |
|
8
Align Technology
ALGN
$10.3B
| $66.4M | 2.08% | 275,207 +105,955 | +63% | +$25.6M |
|
9
Maravai LifeSciences
MRVI
$350M
| $64.6M | 2.03% | 9,024,037 +1,802,077 | +25% | +$12.9M |
|
|
10
Vaxcyte
PCVX
$4B
| $61M | 1.91% | 808,303 -404,400 | -33% | -$30.5M |
|
|
11
Spyre Therapeutics
SYRE
$996M
| $59.1M | 1.85% | 2,514,538 +1,999,538 | +388% | +$47M |
|
12
Glaukos
GKOS
$5.5B
| $58.8M | 1.84% | 496,576 +45,900 | +10% | +$5.43M |
|
13
Viking Therapeutics
VKTX
$3.04B
| $58.7M | 1.84% | 1,106,905 +393,805 | +55% | +$20.9M |
|
14
iRhythm Technologies
IRTC
$5.46B
| $56.7M | 1.78% | 526,357 +43,100 | +9% | +$4.64M |
|
|
15
Inspire Medical Systems
INSP
$2.77B
| $50.8M | 1.59% | 379,443 +277,951 | +274% | +$37.2M |
|
|
16
Exact Sciences
EXAS
$8.98B
| $48.2M | 1.51% | +1,141,678 | New | +$48.2M |
|
17
Keros Therapeutics
KROS
$618M
| $44.9M | 1.41% | 982,209 +244,830 | +33% | +$11.2M |
|
18
Intuitive Surgical
ISRG
$170B
| $44.7M | 1.4% | 100,500 | – | – |
|
19
Day One Biopharmaceuticals
DAWN
$769M
| $41.8M | 1.31% | 3,035,904 +862,200 | +40% | +$11.9M |
|
20
Repligen
RGEN
$6.88B
| $40.8M | 1.28% | 323,509 +180,673 | +126% | +$22.8M |
|
|
AVDL
21
Avadel Pharmaceuticals
AVDL
$1.43B
| $40.8M | 1.28% | 2,898,639 +230,090 | +9% | +$3.24M |
|
22
Thermo Fisher Scientific
TMO
$186B
| $39M | 1.22% | 70,449 +23,300 | +49% | +$12.9M |
|
23
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $38.4M | 1.21% | 2,058,303 +665,587 | +48% | +$12.4M |
|
24
Penumbra
PEN
$10.6B
| $38.3M | 1.2% | 212,594 -83,298 | -28% | -$15M |
|
25
OrthoPediatrics
KIDS
$536M
| $31.9M | 1% | 1,107,770 | – | – |
|